SAFE and Convertible Note valuation in India has nothing to do with Section 409A of the US Internal Revenue Code — that provision only applies to companies with a genuine US tax nexus. For an Indian-only iSAFE or Convertible Note round, valuation instead runs through FEMA pricing rules, Section 247 of the Companies Act, Rule 57 of the Income-tax Rules for tax purposes, and Ind AS 32/109 for accounting — and it applies earlier in the process than most founders expect.
1. What “409A” Has to Do With an Indian SAFE or Convertible Note Round
Founders raising a SAFE or Convertible Note round in India often hear the phrase “409A valuation” from an accelerator, a US-based mentor, or an investor’s due-diligence checklist, and assume it is something they need to obtain before closing. Usually, it is not.
Section 409A of the US Internal Revenue Code exists for one specific purpose: setting a defensible fair market value for a private company’s common stock, so that US employee stock options are priced correctly for US tax purposes. It applies where there is a genuine US tax nexus — a Delaware or other US parent, US-resident option holders, or a US subsidiary. It has no application to a purely Indian company issuing an iSAFE or Convertible Note to raise its next round. We cover 409A itself, and exactly when it does apply to an Indian startup, in Can an Indian Valuer Do a 409A Valuation?, who is qualified to prepare one in Who Can Perform a 409A Valuation?, and what it costs where it does apply in 409A Valuation Cost in India.
For a startup with no US nexus, the more useful question isn’t “do we need a 409A” — it’s “which of India’s own valuation frameworks applies, and when.” There are four, and unlike a 409A refresh (which most companies treat as an annual exercise), none of them are optional just because the round’s pricing has been deferred to a future event.
| Framework | Triggered by | What it determines |
|---|---|---|
| FEMA (Non-Debt Instruments Rules, 2019) | Any foreign investor in the round | A pricing floor — the instrument cannot be issued below fair market value |
| Companies Act, 2013 (Section 247) | Private placement or preferential allotment, resident or non-resident investor | Registered Valuer support for the issue price |
| Rule 57, Income-tax Rules, 2026 (the successor to Rule 11UA) | Any issue of shares or CCPS, for income-tax purposes | Fair market value under the NAV or DCF method |
| Ind AS 32 / Ind AS 109 | Company reports under Ind AS | Whether the instrument is equity, a liability, or a hybrid — and whether it needs fair value re-measurement |
Each of these is covered in depth further down, specifically in the context of iSAFE and Convertible Note instruments. First, it helps to be precise about what those instruments actually are under Indian law — because the answer isn’t as simple as “the same SAFE you’d sign in the US.”
2. SAFE, iSAFE, and Convertible Notes: What Indian Startups Are Actually Signing
A SAFE (Simple Agreement for Future Equity) is a fundraising instrument introduced by Y Combinator in 2013. It is not a share and not a loan — it’s a contractual promise that the investor will receive equity at a future financing event, typically the company’s next priced round. Most SAFEs carry a valuation cap, a conversion discount, and provisions for a liquidity event or dissolution. Because there’s no repayment obligation and no maturity date, a SAFE is generally the most founder-friendly instrument of the three.
Indian company law does not recognise a SAFE as a standalone security. A SAFE, as written for a Delaware company, is just a contractual promise to issue shares later — and Indian regulations require an investment instrument to fall within a recognised category: equity shares, Compulsorily Convertible Preference Shares (CCPS), Compulsorily Convertible Debentures (CCD), or a Convertible Note (for eligible startups under the Companies Act framework). To get SAFE-like economics inside that structure, Indian startups use an iSAFE — in practice, CCPS with the valuation cap, discount, and conversion-trigger terms drafted directly into the share terms. The commercial outcome for the investor is close to a US SAFE; the legal form is Indian equity from day one.
A Convertible Note is structured differently again. It begins life as debt: the company borrows a principal amount, usually at a stated interest rate, with a maturity date and defined conversion triggers (most commonly, the next qualified financing round). No shares are issued at signing. If a qualifying event never happens before maturity, the principal — and any accrued interest — can become repayable in cash, which is the one meaningful downside risk a Convertible Note carries that an iSAFE does not.
| iSAFE (via CCPS) | Convertible Note | |
|---|---|---|
| Legal form | Equity from day one | Debt until conversion |
| Interest | None | Usually yes — typically converts into equity along with the principal |
| Maturity / repayment risk | None — no repayment obligation | Yes — principal (plus accrued interest) can fall due if no qualifying event occurs before maturity |
| Valuation matters most at | Issuance (especially with a foreign investor) and conversion | Primarily at conversion |
Both instruments share the same core mechanic that makes valuation relevant twice rather than once: a valuation cap sets the maximum company valuation used to calculate the investor’s conversion price, and a conversion discount gives the investor a percentage off the price paid by new investors in the triggering round. Many agreements carry both, with the investor converting at whichever produces the lower price. Both mechanics are explained in worked detail, with real numbers, further down this guide.
3. When Does Valuation Become Mandatory? The Four Frameworks in Detail
3.1 Foreign Investors: FEMA Pricing
If any investor in the round is a non-resident, the Foreign Exchange Management (Non-Debt Instruments) Rules, 2019 set the governing principle: shares or convertible instruments issued to a non-resident cannot be priced below fair market value, determined using an internationally accepted valuation methodology. This applies to an iSAFE at issuance even though its commercial price is deferred — the company still needs a defensible FMV to demonstrate the round wasn’t priced below the floor. Depending on the transaction, that FMV needs to be supported by a Chartered Accountant, a Cost Accountant, or — where the transaction specifically calls for it — a SEBI Category-I Merchant Banker’s certificate, obtained as part of the same coordinated engagement rather than as a separate, disconnected exercise. For a closer look at how FEMA pricing works across transaction types, see our FEMA Valuation Rules Under RBI guide.
3.2 Domestic Fundraising: Companies Act, 2013
Section 247 of the Companies Act, 2013 introduced Registered Valuers — professionals registered with the Insolvency and Bankruptcy Board of India (IBBI) and authorised to value companies for corporate-law purposes. Whenever a company issues CCPS, CCDs, or equity shares through private placement or preferential allotment — which is exactly how an iSAFE or a converted Convertible Note gets documented — an independent valuation report has become standard practice to support the issue price, the board resolution, and the private placement filing, regardless of whether every investor is Indian. It also becomes the reference point founders and investors return to if the pricing is ever questioned later.
3.3 Tax Compliance: Rule 57 of the Income-tax Rules, 2026
Fair market value for Indian income-tax purposes is determined under Rule 57 of the Income-tax Rules, 2026 (enacted under the Income Tax Act, 2025) using the Net Asset Value or Discounted Cash Flow method. Up to 31 March 2026, this was Rule 11UA of the Income-tax Rules, 1962 — same substance, new numbering, and “Rule 11UA” is still the term most founders and advisors use in conversation.
This rule is most associated with “angel tax” under the now-repealed Section 56(2)(viib), which used to tax a company on share premium received above fair market value. Angel tax has been fully abolished, for all companies, with effect from Assessment Year 2025-26 — not merely reduced for DPIIT-recognised startups, as it’s sometimes still described. That said, a Rule 57 valuation remains good practice when issuing an iSAFE or documenting a Convertible Note’s conversion: it supports the issue price, gives the company a defensible position if a transaction is ever queried, and provides the documentation base auditors and future investors will expect to see. For more on Merchant Banker-certified valuations generally, see Merchant Banker Valuation in India, and for the income-tax valuation report itself, see our guide to the income-tax valuation report.
3.4 Financial Reporting: Ind AS 32 and Ind AS 109
Once funds are raised, the accounting question begins. Companies reporting under Indian Accounting Standards must classify each iSAFE or Convertible Note under Ind AS 32 and Ind AS 109 as equity, a financial liability, or a hybrid instrument with both components — based on its actual contractual terms, not its label. Fixed conversion terms with no repayment obligation generally support equity classification. Variable conversion ratios, redemption rights, or other features that could require the company to deliver cash push the instrument toward liability classification — which then requires the instrument to be re-measured at fair value at every reporting date, not just once at issuance. This is covered in more depth in Section 8 below.
4. How Valuation Works for an iSAFE
Because an iSAFE is CCPS from the moment it’s issued, valuation is relevant twice: once at issuance, and again at conversion.
At issuance, even though the commercial price is deferred to a future round, the company still needs a defensible FMV — to satisfy FEMA where there’s a foreign investor, to support the board and private placement documentation under the Companies Act, and to give both sides a reference point for how the cap and discount were set in the first place.
The valuation cap sets the maximum company valuation used to calculate the investor’s conversion price, regardless of what the company is actually worth when the triggering round happens. It exists to reward the investor for taking risk earlier than the round’s eventual lead. The conversion discount gives the investor a straight percentage off the price per share paid by new investors in that round. Where an agreement includes both, the investor typically converts at whichever price is lower — the mechanics are worked through with real numbers in Section 7.
At conversion, the company has to determine the triggering round’s share price, work out whether the cap or the discount produces the better price for the investor, calculate the resulting share count, and confirm the resulting ownership percentages — then keep the whole calculation, and the valuation evidence behind it, on file. Getting this wrong doesn’t just create an internal dispute; it can over- or under-dilute existing shareholders, delay the regulatory filings the conversion triggers, and complicate the cap table for the next round.
Where a foreign investor is converting, the FEMA pricing floor applies again at conversion, not just at issuance — the conversion price still has to clear fair market value. And depending on the CCPS terms, the instrument’s Ind AS classification (equity versus liability) may itself have required periodic fair value re-measurement in the period between issuance and conversion, independently of the commercial conversion mechanics.
5. How Valuation Works for a Convertible Note
A Convertible Note shifts the centre of gravity from issuance to conversion. Because no shares exist until conversion, there’s comparatively little for a valuer to certify at signing beyond the FMV support a foreign lender-investor may still need under FEMA. Most of the valuation work happens later.
At conversion, the company works through the same comparison as an iSAFE — the triggering round’s price, the discounted price, and the valuation-cap-implied price — and converts at whichever is more favourable to the investor under the agreement’s terms. Where the note carries interest, the accrued amount typically converts into equity alongside the principal, so the valuation exercise also has to determine the total conversion amount (principal plus interest), not just the per-share price.
Once the note converts, the regulatory filings follow the same path as a fresh equity issuance — board approval, share allotment, updated cap table, and any FEMA-related filing the investor’s residency status triggers — supported by the valuation documentation behind the conversion price.
6. Valuation Methods Used for SAFE and Convertible Note Companies
There’s no single prescribed method for valuing an early-stage company raising through an iSAFE or Convertible Note. Indian frameworks generally accept internationally recognised methodologies, and the right one depends on the company’s stage, financial maturity, and the purpose the valuation is being prepared for.
| Method | How it works | Best suited to |
|---|---|---|
| Discounted Cash Flow (DCF) | Projects future free cash flows and discounts them to present value | Scalable, high-growth companies with credible projections — the most commonly used method for venture-backed startups |
| Net Asset Value (NAV) | Fair market value of assets, less liabilities | Asset-heavy or holding-company structures; the prescribed method under Rule 57 alongside DCF |
| Market Multiple | Applies revenue, EBITDA, or enterprise-value multiples from comparable listed or funded companies | Companies with meaningful revenue and identifiable comparables; often used to sense-check a DCF |
| Comparable Transactions | Benchmarks against recent funding or acquisition prices for similar private companies | Sectors with active, reasonably transparent deal flow |
| Probability-Weighted Scenario Analysis | Assigns probabilities to multiple future outcomes (fresh round, acquisition, IPO, wind-down) and blends them | Instruments like iSAFEs and Convertible Notes that convert differently depending on which future actually happens |
| Option Pricing / Monte Carlo Models | Models the cap, discount, and conversion triggers as option-like features and simulates outcomes | Notes and CCPS with multiple conversion triggers, anti-dilution clauses, or other complex contractual features |
Most professional reports lean on one primary method — DCF, for most startups — with a second method used as a reasonableness check, and (for the instrument itself, as opposed to the underlying company) probability-weighting or option-pricing layered on top to capture the cap and discount mechanics.
7. Worked Examples: How the Numbers Actually Play Out
The mechanics above are easier to follow with real numbers. Both examples below are illustrative, not drawn from an actual engagement.
7.1 iSAFE (CCPS) From a Foreign Angel Investor
An early-stage SaaS company raises ₹50 lakh from an overseas angel through an iSAFE structured as CCPS, with a ₹15 crore valuation cap and a 20% discount, converting on the next qualified financing round. Because the investor is a non-resident, the company obtains an independent FEMA-compliant valuation before issuing the CCPS.
Eighteen months later, a venture fund leads a Series A at a ₹50 crore pre-money valuation, pricing new shares at ₹500 each. The iSAFE now converts:
| Method | Conversion price |
|---|---|
| Series A price | ₹500 |
| 20% discount price | ₹400 |
| Valuation cap price (implied by ₹15 crore cap on the pre-Series A cap table) | ₹150 |
Since the agreement converts at whichever price is more favourable to the investor, and ₹150 is the lowest of the three, the CCPS converts at the cap price — giving the angel substantially more shares than a new Series A investor buying in at ₹500. Once conversion completes, the company records the board approval, updates the cap table, files the applicable regulatory forms, and retains the original valuation report as supporting documentation.
7.2 Convertible Note From a Domestic Angel Investor
A DPIIT-recognised startup raises ₹50 lakh in bridge financing through a Convertible Note: 7% annual interest, a ₹8 crore valuation cap, a 20% discount, and a 10-year maturity. No shares are issued at signing.
Two years later, the company closes a Series A at a ₹12 crore pre-money valuation, with new shares priced at ₹1,200. The note converts:
| Method | Share price |
|---|---|
| Series A price | ₹1,200 |
| 20% discount price | ₹960 |
| Valuation cap price (implied by ₹8 crore cap) | ₹800 |
The note converts at ₹800 — the lower of the three — and because the agreement lets accrued interest convert alongside the principal, the total conversion amount (not just the ₹50 lakh principal) is divided by ₹800 to arrive at the final share count. The investor ends up with more shares than either the discount alone or the Series A price would have produced, compensating them for funding the company at a materially earlier and riskier stage.
Working through the cap table math for your own iSAFE or Convertible Note round?
We prepare the valuation, the FEMA and Companies Act documentation, and coordinate any Merchant Banker certificate the round also requires — as one engagement, rather than three advisors working from different assumptions.
8. Tax and Accounting Treatment
8.1 At Issuance
An iSAFE, issued as CCPS, is treated as an equity-related instrument from a company-law perspective — the funds received strengthen the capital structure and are not operating income. A Convertible Note is initially recognised as a financial liability (borrowed capital), not income, with interest expense recognised over its life under the applicable accounting standard.
8.2 At Conversion
When an iSAFE converts, the investor exchanges one instrument for another; the company issues shares, updates its registers, and reflects the transaction in its financial statements — without generating operating income, since no new revenue has been created. When a Convertible Note converts, the liability comes off the balance sheet and equity increases by the same amount, with no cash outflow — which, for many startups, strengthens the balance sheet ahead of the next round. Investors typically don’t face a tax event at conversion itself; capital gains considerations generally arise later, when the resulting shares are eventually sold, and depend on the investor’s residency, holding period, and the tax law in force at that time.
8.3 Equity or Liability: The Ind AS 32 / 109 Question
The classification question turns on the instrument’s actual contractual terms, not its commercial label. An instrument tends toward equity classification when its conversion terms are fixed, the resulting share count is predetermined, and the company has no obligation to deliver cash. It tends toward liability classification when it carries a variable conversion ratio, a redemption right, a cash-settlement option, or certain anti-dilution mechanics — features that are common in more heavily negotiated iSAFE and Convertible Note terms.
Liability classification isn’t just a balance-sheet label — it requires the instrument to be re-measured at fair value at every reporting date until it converts or is settled, using DCF, probability-weighted scenarios, or option-pricing models as appropriate. That’s a materially larger ongoing commitment than a one-time valuation at issuance, and it’s worth confirming the classification — and therefore the ongoing valuation obligation — before the round closes, not after the first audit.
9. The Valuation Process, Step by Step
- Identify the instrument and the investor profile. An iSAFE, a Convertible Note, and straight CCPS each trigger a different regulatory path, and a foreign investor adds FEMA to the list regardless of which instrument is used.
- Confirm regulatory eligibility. Check that the Articles of Association permit the proposed instrument, that the company qualifies to issue a Convertible Note if that’s the route chosen, and that the necessary corporate approvals are achievable on the fundraising timeline.
- Appoint a qualified valuation professional — a Registered Valuer, Chartered Accountant, or SEBI Category-I Merchant Banker, depending on which certificate the transaction requires.
- Gather the underlying information — historical financials, management accounts, revenue projections, the cap table, prior funding documents, and the draft iSAFE or Note agreement itself, including its cap and discount terms.
- Select the valuation methodology from Section 6 above, based on the company’s stage and the purpose of the valuation.
- Perform the valuation analysis, incorporating the instrument’s specific features — the cap, the discount, expected timing of conversion, and any anti-dilution or liquidation terms that could affect the outcome.
- Prepare the valuation report, documenting the purpose, valuation date, methodology, key assumptions, and the resulting fair market value.
- Review pricing compliance and complete the filings — confirm the price clears the FEMA floor where relevant, matches the Companies Act documentation, and is consistent with the Rule 57 position, then complete the board resolutions, private placement filing, and any FEMA-related filing the transaction triggers.
10. Common Valuation Mistakes to Avoid
- Assuming deferred pricing means no valuation is needed. An iSAFE or Note defers the commercial price; it doesn’t defer the FEMA, Companies Act, or tax-documentation requirements that apply at issuance.
- Using unrealistic projections. Inflated growth assumptions produce a valuation that won’t hold up in due diligence for the next round.
- Applying the wrong methodology — NAV rarely suits a pre-revenue SaaS company; DCF rarely suits an asset-heavy holding structure.
- Treating the FEMA, Companies Act, and Ind AS questions as separate exercises instead of one coordinated engagement, which tends to produce inconsistent assumptions across the three.
- Skipping documentation. A valuation without a paper trail of assumptions, board approvals, and calculations is difficult to defend later.
- Not revisiting the valuation after a material event — a new round, a strategic shift, or a significant change in performance.
- Overlooking the Ind AS classification question until the first audit, by which point a liability-classified instrument may already be carrying an unaddressed fair-value re-measurement obligation.
11. Compliance Checklist for Founders Raising Through an iSAFE or Convertible Note
Before the round
- Confirm the instrument (iSAFE/CCPS, Convertible Note, or CCD) fits the company’s stage and investor mix
- Review the AoA, cap table, and any existing investment agreements for consistency with the new instrument
- Organise historical financials, projections, and business plan
- Engage a Registered Valuer, CA, or Merchant Banker as the transaction requires
During the round
- Obtain the independent valuation and confirm it clears the FEMA floor, where applicable
- Finalise the cap, discount, conversion triggers, and other terms in the investment agreement
- Obtain board and, where required, shareholder approval
- Confirm the Ind AS classification of the instrument before signing, not after
After the round
- Complete share allotment and FEMA-related filings within the prescribed timelines
- Update the cap table and statutory registers
- Retain the valuation report and supporting calculations for future rounds, audits, and due diligence
- Flag the instrument for review at the next reporting date if it’s classified as a liability
Download: iSAFE and Convertible Note Fundraising Compliance Checklist
A one-page version of the checklist above, covering the corporate approvals, valuation, and filing steps before, during, and after the round — email us and we will send it across.
12. Frequently Asked Questions
Q1. Do we need a 409A valuation for our Indian iSAFE or Convertible Note round?
Only if there’s a genuine US tax nexus — a Delaware or other US parent, US-resident option holders, or a US subsidiary. A purely Indian round uses the frameworks covered in this guide (FEMA, Companies Act, Rule 57, Ind AS) instead. See 409A Valuation Cost in India for when the requirement is actually triggered.
Q2. Does raising through a SAFE or Convertible Note eliminate the need for a valuation?
No. It defers the commercial price to a future round, but valuation support is still typically needed at issuance for FEMA and Companies Act purposes, and is central to the conversion calculation later.
Q3. When should a startup obtain a valuation for an iSAFE or Convertible Note round?
Before issuing the instrument (particularly with a foreign investor), again immediately before conversion, and whenever a material business event — a new round, a significant change in performance, or a strategic shift — could affect the numbers.
Q4. Which valuation method is most commonly used?
DCF is the most common for high-growth startups, often supported by a market-multiple or comparable-transaction check. Rule 57 specifically recognises NAV and DCF for income-tax purposes.
Q5. Who can prepare the valuation report?
Depending on the transaction: an IBBI-Registered Valuer, a Chartered Accountant, or — where the transaction specifically requires it — a SEBI Category-I Merchant Banker’s certificate, obtained as part of the same coordinated engagement.
Q6. What happens if a startup skips the valuation process?
Common consequences include delayed fundraising, investor due-diligence concerns, regulatory queries on the filed price, avoidable tax exposure, and complications when the next round tries to build on an undocumented cap table.
Q7. Is a valuation cap the same as the company’s valuation?
No. A valuation cap is a contractual ceiling used only to calculate the investor’s conversion price — it isn’t a statement of what the company is actually worth, which can be, and often is, considerably higher by the time the triggering round happens.
Q8. Can an iSAFE or Convertible Note include both a valuation cap and a discount?
Yes, and it’s common. Where both are present, the agreement typically specifies that the investor converts at whichever produces the lower price — worked through with real numbers in Section 7 above.
Q9. Do we need a fresh valuation for every funding round?
Not automatically, but it’s good practice after a major round, a significant change in revenue or performance, a new instrument, or any material restructuring — rather than relying on a valuation that predates the company’s current position.
Q10. How is this different from a 409A valuation?
A 409A prices US common stock for US stock-option purposes and applies only where there’s a US tax nexus. The valuation covered in this guide prices the iSAFE or Convertible Note itself, or the underlying Indian company, for FEMA, Companies Act, tax, and Ind AS purposes — a separate exercise that most Indian-only startups need regardless of whether a 409A ever becomes relevant. If your round does have a US tax nexus, see 409A Valuation After a Funding Round for how that number is actually determined.
Structuring an iSAFE or Convertible Note round?
Marcken Consulting prepares the valuation alongside the FEMA and Companies Act documentation the same round requires, and coordinates any Merchant Banker’s certificate the transaction calls for within the same engagement. A no-charge 30-minute consultation is a good place to start.
Marcken Consulting LLP | CA Murli Chandak — IBBI-Registered Valuer (Securities or Financial Assets)
Website: marckenconsulting.com
Phone: +91 99980 59923 / +91 99985 39902
Email: crm@marckenconsulting.com
